Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
Compare Profit and Loss Results of Novartis India
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
309.00
47.00
15.21%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
309.00
47.00
15.21%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-23.00
26.00
113.04%
Raw Materials Consumed
199.00
125.00
74.00
59.20%
Power & Fuel Cost
0.00
28.00
-28.00
-100.00%
Employee Cost
18.00
97.00
-79.00
-81.44%
Operating Expenses
8.00
43.00
-35.00
-81.40%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
5.00
5.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
11.00
-2.00
-18.18%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
316.00
-52.00
-16.46%
Operating Profit (PBDIT) excl Other Income
91.00
-6.00
97.00
1,616.67%
Other Income
41.00
16.00
25.00
156.25%
Operating Profit (PBDIT)
133.00
9.00
124.00
1,377.78%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
132.00
-5.00
137.00
2,740.00%
Depreciation
2.00
20.00
-18.00
-90.00%
Profit Before Taxation & Exceptional Items
130.00
-26.00
156.00
600.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
-26.00
156.00
600.00%
Provision for Tax
29.00
-10.00
39.00
390.00%
Profit After Tax
100.00
-15.00
115.00
766.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
-173.00
901.00
520.81%
Profit Available for appropriations
829.00
-189.00
1,018.00
538.62%
Appropriations
829.00
-189.00
1,018.00
538.62%
Equity Dividend (%)
500%
0%
500.00
Earnings Per Share
40.87
-2.49
43.36
1,741.37%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
